[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- [Investors See Opportunity in Huge Global Demand for Lithium]() [Put this company on your investing radar today.]() --------------------------------------------------------------- October 5, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [GRAPHITE: "Essential for America's National Defense"]( you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider. [Discover Who's Poised to Benefit In The U.S. vs. China Energy War]() --------------------------------------------------------------- [Immunovant, IMVT](=) Recent Analyst Action: Douglas Tsao, analyst at H.C. Wainwright, reiterates coverage on [Immunovant (IMVT)](=)in the Healthcare sector with a Buy rating (6 days ago). - Recent Price: $9.145 - Average Analyst Price Target: $8.75 (-4.32%) - Market Cap: $952.44M [TipRanks.com]( also reports that [Immunovant](currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.75. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $5.00. [Immunovant (IMVT)]()’s last closing price was $9.145 which would put the average price target at $8.75. Here are 3rd party ratings for [IMVT](=): - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 24% (61 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [Bear Market Legend Details 25 Stocks to Sell Now]( A legendary bear market investor believes the situation could get worse in 2022… [Learn how to get the names of the companies he says you MUST avoid.]( --------------------------------------------------------------- [Circor International, CIR]() Recent Analyst Action: Nathan Jones, analyst at Stifel Nicolaus, reiterates coverage on [Circor International (CIR)]()in the Industrial Goods sector with a Buy rating and a price target of $25.00 (2 days ago). - Recent Price: $19.26 - Average Analyst Price Target: $24.33 (26.32%) - Market Cap: $385.85M [TipRanks.com]( also reports that [Circor International](=)currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $24.33. The target pricing ranges from a high forecast of $27.00 down to a low forecast of $21.00. [Circor International (CIR)](’s last closing price was $19.26 which would put the average price target at $24.33. Here are 3rd party ratings for [CIR](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Strong Sell, Bottom 18% (205 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- [IVERIC bio, ISEE](=) Recent Analyst Action: Annabel Samimy, analyst at Stifel Nicolaus, reiterates coverage on [IVERIC bio (ISEE)]()in the Healthcare sector with a Buy rating and a price target of $35.00 (3 weeks ago). - Recent Price: $21.21 - Average Analyst Price Target: $27.50 (29.66%) - Market Cap: $2.34B [TipRanks.com]( also reports that [IVERIC bio](currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $27.50. The target pricing ranges from a high forecast of $35.00 down to a low forecast of $8.00. [IVERIC bio (ISEE)](’s last closing price was $21.21 which would put the average price target at $27.50. Here are 3rd party ratings for [ISEE](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 24% (61 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]() [Click here]( for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- [NOV, NOV]( Recent Analyst Action: Marc Bianchi, analyst at Cowen & Co., reiterates coverage on [NOV (NOV)](=)in the Industrial Goods sector with a Buy rating and a price target of $21.00 (1 day ago). - Recent Price: $17.89 - Average Analyst Price Target: $21.13 (18.11%) - Market Cap: $6.90B [TipRanks.com]( also reports that [NOV](currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $21.13. The target pricing ranges from a high forecast of $27.00 down to a low forecast of $16.00. [NOV (NOV)](’s last closing price was $17.89 which would put the average price target at $21.13. Here are 3rd party ratings for [NOV](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Strong Buy, Bottom 43% (144 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Now, DNOW](=) Recent Analyst Action: Nathan Jones, analyst at Stifel Nicolaus, reiterates coverage on [Now (DNOW)](=)in the Industrial Goods sector with a Buy rating and a price target of $14.00 (2 months ago). - Recent Price: $11.53 - Average Analyst Price Target: $13.67 (18.56%) - Market Cap: $1.26B [TipRanks.com]( also reports that [Now](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $13.67. The target pricing ranges from a high forecast of $14.00 down to a low forecast of $13.00. [Now (DNOW)]()’s last closing price was $11.53 which would put the average price target at $13.67. Here are 3rd party ratings for [DNOW](): - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Strong Buy, Top 11% (28 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush."]() Experts predict that the global lithium market will balloon by 500%. That's wonderful news for investors, because a "sure-thing" like this appears once in a lifetime. And this small-cap company just snagged what could be one of the world's largest lithium deposits. [Discover This Company's MASSIVE Lithium Opportunity!]() --------------------------------------------------------------- [Transphorm, TGAN]( Recent Analyst Action: David Williams, analyst at Benchmark Co., reiterates coverage on [Transphorm (TGAN)](in the Technology sector with a Buy rating and a price target of $8.00 (1 month ago). - Recent Price: $5.4 - Average Analyst Price Target: $8.00 (48.15%) - Market Cap: $301.19M [TipRanks.com]() also reports that [Transphorm](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $8.00 down to a low forecast of $8.00. [Transphorm (TGAN)](=)’s last closing price was $5.4 which would put the average price target at $8.00. Here are 3rd party ratings for [TGAN](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Bottom 36% (160 out of 251) [Click here for chart >>](=) -------------------------------------------------------------------------- [SCYNEXIS, SCYX](=) Recent Analyst Action: Michael Higgins, analyst at Ladenburg Thalmann & Co., reiterates coverage on [SCYNEXIS (SCYX)]()in the Healthcare sector with a Buy rating and a price target of $15.00 (1 month ago). - Recent Price: $2.53 - Average Analyst Price Target: $11.33 (347.83%) - Market Cap: $83.26M [TipRanks.com]( also reports that [SCYNEXIS]()currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $11.33. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $8.00. [SCYNEXIS (SCYX)]()’s last closing price was $2.53 which would put the average price target at $11.33. Here are 3rd party ratings for [SCYX](=): - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 30% (75 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [The Biggest "Missing Ingredient" in the $7 Trillion EV Market]() China has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market. [Don't Miss Your Opportunity to Benefit from This Breaking News](=) = --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketSectorDaily.com [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States (877) 411-9808